Pulmocide.com

Keyword Suggestion

Pulmocide

Pulmocide therapeutics

Pulmocide limited

Pulmocide.com zoominfo

Pulmocide jobs

Pulmocide careers

Pulmocide medication

Pulmocide companies house

Domain Informations

Whois Informations
Top 10 Domain Provider

Pulmocide.com lookup results from whois.register.it server:

Network

Owner

Technical support

Abuse

Domain Provider	Number Of Domains
godaddy.com	286730
namecheap.com	101387
networksolutions.com	69118
tucows.com	52617
publicdomainregistry.com	39120
whois.godaddy.com	32793
enomdomains.com	23825
namesilo.com	21429
domains.google.com	21384
cloudflare.com	20573
gmo.jp	18110
name.com	17601
fastdomain.com	14708
register.com	13495
net.cn	12481
ionos.com	12416
ovh.com	12416
gandi.net	12305
registrar.amazon.com	12111

Host Informations

Check all domain's dns records

See Web Sites Hosted on 45.76.139.2

Fetching Web Sites Hosted

Site Inspections

Port Scanner (IP: 45.76.139.2)

› Ftp: 21

› Ssh: 22

› Telnet: 23

› Smtp: 25

› Dns: 53

› Http: 80

› Pop3: 110

› Portmapper, rpcbind: 111

› Microsoft RPC services: 135

› Netbios: 139

› Imap: 143

› Ldap: 389

› Https: 443

› SMB directly over IP: 445

› Msa-outlook: 587

› IIS, NFS, or listener RFS remote_file_sharing: 1025

› Lotus notes: 1352

› Sql server: 1433

› Point-to-point tunnelling protocol: 1723

› My sql: 3306

› Remote desktop: 3389

› Session Initiation Protocol (SIP): 5060

› Virtual Network Computer display: 5900

› X Window server: 6001

› Webcache: 8080

Spam Check (IP: 45.76.139.2)

› Dnsbl-1.uceprotect.net:

› Dnsbl-2.uceprotect.net:

› Dnsbl-3.uceprotect.net:

› Dnsbl.dronebl.org:

› Dnsbl.sorbs.net:

› Spam.dnsbl.sorbs.net:

› Bl.spamcop.net:

› Recent.dnsbl.sorbs.net:

› All.spamrats.com:

› B.barracudacentral.org:

› Bl.blocklist.de:

› Bl.emailbasura.org:

› Bl.mailspike.org:

› Bl.spamcop.net:

› Cblplus.anti-spam.org.cn:

› Dnsbl.anticaptcha.net:

› Ip.v4bl.org:

› Fnrbl.fast.net:

› Dnsrbl.swinog.ch:

› Mail-abuse.blacklist.jippg.org:

› Singlebl.spamgrouper.com:

› Spam.abuse.ch:

› Spamsources.fabel.dk:

› Virbl.dnsbl.bit.nl:

› Cbl.abuseat.org:

› Dnsbl.justspam.org:

› Zen.spamhaus.org:

Email address with pulmocide.com

Found 2 emails of this domain
1. [email protected]
2. [email protected]

Recent Searched Sites

› Mundoceys.com (59 seconds ago) / NL

› Shop-sks.com (4 seconds ago) / DE

› Narindashop.online (3 seconds ago) / US

› En.benvolio.bio (15 seconds ago) / FR

› Lootlocker.com (5 seconds ago) / US

› Pulmocide.com (0 seconds ago) / GB

› Saepe.it (34 seconds ago) / IT

› Psdocs.spes.vt.edu (3 seconds ago) / US

› Logsplitterpicks.com (27 seconds ago) / US

› Mglab.id (7 seconds ago) / ID

› Cityofsalinas.opendatasoft.com (1 mins ago) / US

› Forum.spbu.ru (12 seconds ago) / RU

› Viewnetcomputers.com (30 seconds ago) / US

› Asimod.com.tr (4 seconds ago) / TR

› Tsouz.belgiss.by (12 seconds ago) / BY

› Jsoi2020.com (26 seconds ago) / US

› Argsygaming.com (34 seconds ago) / US

› Asianlilychinese.com.au (34 seconds ago) / US

› Nairablink.com (14 seconds ago) / US

› Freakyfontgenerator.top (1 seconds ago) / US

List of our tools

Emails by domain

Mobile Friendly Check

Page Speed Check

DNS Lookup

Ports Scan

Sites on host

Sitemap Generator

Websites Listing

We found Websites Listing below when search with pulmocide.com on Search Engine

Pulmocide

– Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company developing novel inhaled therapies for patients suffering from serious acute and chronic respiratory diseases, today announced it has raised $92 million […] 27 May 2021. Read more. Pulmocide announces publication of clinical data in two peer-reviewed publications highlighting potential of PC945, a …

Pulmocide.com

Investors – Pulmocide

SV Health Investors, formerly SV Life Sciences, is a leading healthcare and life sciences venture capital and growth equity firm.Our goal is to transform healthcare – one investment at a time – by supporting the entrepreneurs who create and build breakthrough companies and treatments. With over $2.9 billion in capital commitments raised ...

Pulmocide.com

Pulmocide | Company Email | Telephone | Contact Details

Contact details (email, telephone numbers etc.) for Pulmocide

Pharmacompass.com

Company news – Pulmocide

Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945. – Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company developing novel inhaled therapies for patients suffering from serious acute and chronic respiratory diseases, today announced it has raised $92 million […] 27 May 2021 ...

Pulmocide.com

PULMOCIDE LIMITED overview - Find and update company …

People for PULMOCIDE LIMITED (06182024) More for PULMOCIDE LIMITED (06182024) Registered office address Office Suite 3.01 44 Southampton Buildings, London, England, WC2A 1AP . Company status Active Company type Private limited Company Incorporated on 23 March 2007 . Accounts. Next ...

Find-and-update.company-information.service.gov.uk

Press Release Distribution and Management - GlobeNewswire

2021-09-15 · Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 London, UK, 27 May 2021 – Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company...

Globenewswire.com

Pulmocide Ltd - Company Profile and News - Bloomberg Markets

Company profile page for Pulmocide Ltd including stock price, company news, press releases, executives, board members, and contact information

Bloomberg.com

Pulmocide - Hired

Pulmocide is a biopharmaceutical company with a mission to treat common acute and chronic respiratory tract infections. Jobs At Similar Companies Director, SG&A Enterprise Platforms Architect - Orchard Therapeutics

Hired.com

Pulmocide Ltd - IP Group plc

2021-05-27 · Email alerts; Media contacts; Events; 20 in 21. IP Group History; The ideas we back aim to change and positively impact the world. Home / Media / Portfolio news / 2021. Pulmocide Ltd - Raises $92 million in a Series C financing to fund registration program for PC945 . 27 May 2021. Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company developing …

Ipgroupplc.com

Pulmocide raises $ 92 million in Series C financing for

2021-05-27 · Bollyinside Breaking USA & World News. Thursday, June 9, 2022

Skfweb.dcmusic.ca

Pulmocide | CipherBio

Explore Pulmocide's investment information, scientific platforms, therapeutic approaches, indications and more here! Explore Pulmocide's investment information, scientific platforms, therapeutic approaches, indications and more here! Home. PRO Data. Investor Insights. VC Funds Raised. M&A Insights. IPO Insights. Investors . Lead Investors. Accelerators & …

Cipherbio.com

Pulmocide Company Insights, Tech Stack, and Competitors | Slintel

2022-02-11 · Find useful insights on Pulmocide’s company details, tech stack, news alerts, competitors and more. Use Slintel to connect with top decision-makers at Pulmocide.

Slintel.com

Pulmocide Raises $92 million in a Series C Financing to Fund ...

2021-05-27 · Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 London, UK, 27 May 2021 – Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company developing novel inhaled therapies for patients suffering from serious acute and chronic respiratory diseases, today announced it has raised $92 million in an …

Ca.news.yahoo.com

Pulmocide | VentureRadar

Pulmocide has extensive expertise in the design and identification of compounds which have been optimised for the inhaled route of administration. Pulmocide compounds will exhibit excellent lung retention properties and minimal systemic exposure. The delivery of anti-infective agents directly to the lung is expected to provide sustained concentrations in the lung to …

Ventureradar.com

PULMOCIDE LIMITED Company Profile | LONDON, United …

Find company research, competitor information, contact details & financial data for PULMOCIDE LIMITED of LONDON. Get the latest business insights from Dun & Bradstreet.

Dnb.com

Pulmocide CEO and key executive team | Craft.co

Pulmocide's Chairman and Chief Executive Officer is Dan Burgess. Other executives include Alison Murray, Chief Medical Officer; Kaz Ito, Director of Biology and 7 others. See the full leadership team at Craft.

Craft.co

Pulmocide Raises $92 million in a Series C Financing to Fund ...

2021-05-27 · Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support

Bloomberg.com

Domains Expiration Date Updated

Site	Provider	Expiration Date
thecoconutcreative.co	opensrs.com	-1 Years, -357 Days
justmysocks5.net	cloudflare.com	-2 Years, -161 Days
dimo.zone	gandi.net	-1 Years, -219 Days
ndupc.com	namecheap.com	-1 Years, -213 Days
burg-hohenzollern.com	ionos.com	-1 Years, -253 Days
ptnn.bz		-1 Years, -251 Days
wrcog.org	networksolutions.com	186 Days
marketingresearchbureau.com	tucows.com	1 Year, 114 Days
onemagvn.com	onlinenic.com	-2 Years, -44 Days
carpfishinguk.org	namecheap.com	-2 Years, -13 Days

Browser All